Shallcross Steven A Synthetic Biologics, Inc. (SYN) insider trading activity

Shallcross Steven A is CEO and CFO of Synthetic Biologics, Inc.. Currently has a direct ownership of 250,000 shares of SYN, which is worth approximately $150,000. The most recent transaction as insider was on Jun 07, 2023, when has been sold 14,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $9,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K

0% 3M change

0% 12M change

Total Value Held $150,000

SHALLCROSS STEVEN A Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 07 2023	BUY Open market or private purchase	$9,660 $0.69 p/Share	14,000 Added 5.3%	250,000 Common Stock
Jun 06 2023	BUY Open market or private purchase	$16,380 $0.63 p/Share	26,000 Added 9.92%	236,000 Common Stock
Feb 10 2023	BUY Open market or private purchase	$26,000 $1.04 p/Share	25,000 Added 10.64%	210,000 Common Stock
Feb 02 2023	BUY Open market or private purchase	$23,500 $0.94 p/Share	25,000 Added 11.9%	185,000 Common Stock
Jan 25 2023	BUY Open market or private purchase	$21,750 $0.87 p/Share	25,000 Added 13.51%	160,000 Common Stock
Jan 20 2023	BUY Open market or private purchase	$18,750 $0.75 p/Share	25,000 Added 15.63%	135,000 Common Stock
Dec 29 2022	BUY Open market or private purchase	$44,000 $0.44 p/Share	100,000 Added 47.62%	110,000 Common Stock
May 10 2021	BUY Open market or private purchase	$24,500 $0.49 p/Share	50,000 Added 33.33%	100,000 Common Stock

Also insider at

ELYS

Elys Game Technology, Corp. Consumer Cyclical

Director

VEEE

Twin Vee PowerCats, Co. Consumer Cyclical

Director

SSA